New cash shell Spiritus Mundi wants to buy a clinical diagnostics business. No formal discussions have begun.
Diagnostics is an area that has gained plenty of publicity in the past three years. There has been a boost to demand from Covid-19 although the peak was passed a long time ago.
The share price ended the week at 6p (5p/7p). There were no trades recorded. The pro forma net assets are just over 2p a share. More cash could be raised if warrants and options are exercised.
The lack of liquidity and premium to net assets mean that it is best to watch progress before considering investing.
===...
